Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that has accused him of “misconduct or inappropriate behavior.”

Robert F. Kennedy Jr. says he won't collect fees from litigation against the drugmakers of a cervical cancer vaccine if he's confirmed as the nation’s health secretary.

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV vaccine manufacturer.

Robert F. Kennedy Jr., President Trump’s nominee for Health secretary, told senators Friday he will divest his financial stake in a lawsuit against pharmaceutical giant Merck over its

Kennedy’s commitment to walk away from the potential windfall is a major reversal for the nominee, who in his ethics plan submitted to federal officials earlier this month told lawmakers he was entitled to those proceeds so long as the U.S. government wasn’t involved.

Senators had objected to the financial conflict posed by Robert F. Kennedy Jr.’s decision to retain a financial stake in lawsuits against a major drug company. It remains unclear whether any proceeds would be redirected.

Kennedy Jr. earned more than $2.4 million as a consultant referring cases to the law firm Wisner Baum, government records show. Wisner Baum is suing Merck & Co. over allegations that the pharmaceutical company failed to properly warn patients about HPV vaccine risks.

He wants to keep cashing in on lawsuits against drug makers, as his confirmation hearing for health secretary makes clear.

RFK Jr. played a lead role in building a case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, even if confirmed as health secretary.

Kennedy vowed to divest his financial interest in vaccine litigation to his son. Democrats and ethics experts said the arrangement raised further questions.